AxoGen, Inc. to Participate in American Academy of Orthopedic Surgeons (AAOS) 2015 Annual Meeting
ALACHUA, Fla., Mar 23, 2015 (GLOBE NEWSWIRE via COMTEX) —
via PRWEB – AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, announced that it will be highlighting its products at the American Academy of Orthopedic Surgeons (AAOS) 2015 Annual Meeting, March 25-27, 2015 in Las Vegas, NV. AxoGen will feature its full suite of nerve repair products including Avance® Nerve Graft, AxoGuard® Nerve Connector, and AxoGuard® Nerve Protector at Booth #3707.
The AAOS 2015 Annual Meeting is anticipated to include more than 14,000 domestic and international orthopedic surgeons, as well as other healthcare professionals. It is the largest orthopedic meeting in the world, featuring presentations of scientific papers, scientific poster and technical exhibits, instructional courses, educational symposia, and company exhibits.
AxoGen AXGN, +0.98% is a leading medical technology company dedicated to peripheral nerve repair. AxoGen’s portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.
